The outlook of companies tied to Sildenafil's history presents a challenging investment picture . While the initial surge generated substantial gains, generic alternatives have significantly diminished market share . Investing in related pharmaceutical firms now requires a careful assessment of patent rights , evolving patient trends , and the p… Read More